TL;DR
- Prolonged waiting times for trans healthcare are consistently associated with adverse mental health outcomes and are increasingly recognised as a clinical concern rather than merely an administrative issue
- Research consistently shows longer waiting times are associated with increased depression, anxiety, self-harm, and suicidal ideation in trans people
- In many countries, waiting times for a first gender clinic appointment run to years, not months
- Self-medication with unprescribed hormones is a documented adaptive response to limited access, not patient irresponsibility
- Prolonged waiting times are an unresolved problem in trans healthcare systems, not a neutral administrative fact
A waiting list is not a neutral holding pattern. It is a period during which gender dysphoria frequently remains untreated or undertreated, with documented consequences for mental health and quality of life — and in trans healthcare, those consequences are severe enough that the waiting list itself is increasingly being recognised as a clinical problem rather than merely an administrative one.
The evidence is consistent. A 2022 literature review published in European Psychiatry found that longer waiting times for gender identity services were associated with increased suicidal ideation, depression, and self-harm, and decreased overall quality of life. A 2024 mixed-methods study from the Netherlands, published in eClinicalMedicine, found that participants frequently described the waiting period as contributing to worsening anxiety, depression, self-harm, and suicidality, and viewed many of these effects as potentially avoidable. Some participants expressed concern that deterioration in mental health during prolonged waits might complicate subsequent assessments, highlighting tensions inherent in systems that rely heavily on psychiatric evaluation.
The numbers
In the UK — one of the most documented examples globally — the standard for planned elective care is a maximum 18-week wait. Reported estimates for the wait for a first appointment at a gender identity clinic have ranged from around 18 months in earlier analyses to four to five years or longer in more recent reporting, varying by service and year examined. In survey evidence submitted to the Women and Equalities Committee, respondents reported that 88.8% had their mental health adversely affected by wait times, and 79.7% of those with pre-existing mental health conditions reported those conditions being made worse. The same survey found that 63.5% of respondents said wait times had contributed to suicidal ideation, and 32.7% said wait times had contributed to suicidal behaviour. 58.8% reported wait times contributing to thoughts of self-harm, and 39.9% reported wait times contributing to self-harm itself.
These are not outliers. They reflect systemic findings across multiple countries and healthcare systems. Demand for gender-affirming care has increased substantially in recent years while service capacity has not kept pace, creating backlogs that in some places are now measured in years rather than months.
The consequence: self-medication
When systems fail to provide timely access, people find alternatives. Self-medication with unprescribed hormones — obtained online or through informal networks — is a documented and widespread response to inadequate access. Multiple studies have described self-medication with unprescribed hormones as a response to barriers in access rather than simply a consequence of patient risk-taking.
The clinical risks of unmonitored hormone use are real. Without baseline bloods, dose titration, monitoring of testosterone suppression or estradiol levels, or assessment of cardiovascular and thromboembolic risk factors, people are taking hormones in circumstances lacking the monitoring and risk assessment normally provided within formal healthcare systems. Some healthcare systems have responded with bridging prescriptions — where a GP prescribes hormones to a self-medicating patient as a harm reduction measure while they remain on the waiting list. This is pragmatic medicine. It does not solve the underlying problem.
What the system treats as acceptable
Healthcare systems have not consistently achieved the same access timelines for trans care that they seek to provide for many other conditions associated with significant psychological distress. NHS mental health access standards require 95% of patients referred for anxiety or depression treatment to be seen within 18 weeks, and most eating disorder referrals to be seen within 1 to 4 weeks. The standard for gender identity services is the same 18-week elective care benchmark — and even that is being missed by years, not weeks. Trans populations experience substantially higher rates of suicidal ideation and psychological distress than the general population, yet these disparities have not consistently translated into equivalent improvements in service capacity.
The waiting list is not a feature of trans healthcare. It is a failure of it.
⚠️ Note: The UK data cited represents one of the most extensively documented examples. Wait time experiences vary significantly by country, region, and healthcare system. The documented mental health consequences of prolonged waiting are, however, consistent across multiple settings.
Sources
- Henderson N, Selwyn V, Beezhold J, Howard R, Gilmore R, Bartolome I. The impact of Gender Identity Clinic waiting times on the mental health of transitioning individuals. European Psychiatry. 2022;65(S1):S851. doi:10.1192/j.eurpsy.2022.2205
- Mixed-methods population study on waiting for transgender care and its effects on health and equality, the Netherlands. eClinicalMedicine. 2024. The Lancet.
- UK Parliament Women and Equalities Committee, written evidence HSC0100, Health and social care and LGBT communities inquiry.
- Watkinson RE, et al. Gender-related self-reported mental health inequalities in primary care in England: a cross-sectional analysis using the GP Patient Survey. The Lancet Public Health. 2024.
- NHS England. Mental health access and waiting time standards (Talking Therapies and Children and Young People’s Eating Disorder standards).
